These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2165009)

  • 41. The interplay of neurotransmitters in Alzheimer's disease.
    Francis PT
    CNS Spectr; 2005 Nov; 10(11 Suppl 18):6-9. PubMed ID: 16273023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 43. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase.
    Mesulam MM; Geula C
    J Comp Neurol; 1988 Sep; 275(2):216-40. PubMed ID: 3220975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD; Stranahan S; Sumi SM; Raskind M
    Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase.
    Fu AL; Li Q; Dong ZH; Huang SJ; Wang YX; Sun MJ
    Neurosci Lett; 2004 Sep; 368(3):258-62. PubMed ID: 15364407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pathophysiology of dementia.
    Plum F
    Gerontology; 1986; 32 Suppl 1():67-72. PubMed ID: 3732820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dementia without cholinergic deficit.
    Riekkinen PJ; Soininen H; Sirviö J; Reinikainen K; Helkala EL; Paljärvi L
    Gerontology; 1987; 33(3-4):268-72. PubMed ID: 3653707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of GSK-3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats.
    Wang Y; Tian Q; Liu EJ; Zhao L; Song J; Liu XA; Ren QG; Jiang X; Zeng J; Yang YT; Wang JZ
    J Cell Mol Med; 2017 Dec; 21(12):3515-3528. PubMed ID: 28656644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H; Iizuka R
    Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract]   [Full Text] [Related]  

  • 53. A post-mortem study of the cholinergic and GABA systems in senile dementia.
    Rossor MN; Garrett NJ; Johnson AL; Mountjoy CQ; Roth M; Iversen LL
    Brain; 1982 Jun; 105(Pt 2):313-30. PubMed ID: 7082992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease.
    Sabbagh MN; Reid RT; Corey-Bloom J; Rao TS; Hansen LA; Alford M; Masliah E; Adem A; Lloyd GK; Thal LJ
    J Neural Transm (Vienna); 1998; 105(6-7):709-17. PubMed ID: 9826113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.
    Beal MF; MacGarvey U; Swartz KJ
    Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degeneration of the cholinergic innervation of the locus ceruleus in Alzheimer's disease.
    Strong R; Huang JS; Huang SS; Chung HD; Hale C; Burke WJ
    Brain Res; 1991 Feb; 542(1):23-8. PubMed ID: 2054656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of Chinese herb compound Naoyikang on expression of choline acetyltransferase in brain of rats with Alzheimer's disease].
    Geng JS; Zhou AL; Shi HY; Hu YE; Mao JH; Zhu Y
    Zhongguo Zhong Yao Za Zhi; 2008 May; 33(9):1071-4. PubMed ID: 18652361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.
    Sims NR; Bowen DM; Smith CC; Flack RH; Davison AN; Snowden JS; Neary D
    Lancet; 1980 Feb; 1(8164):333-6. PubMed ID: 6101790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease.
    Mesulam MM
    Prog Brain Res; 1996; 109():285-97. PubMed ID: 9009717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.